UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
Grocery Outlet
GO
$1.26B
| $2.19M | ﹤0.01% |
219,642
-19,358
| -8% | -$159K |
2019 Q2
28 quarters
|
|
1977
iShares MSCI Poland ETF
EPOL
$1B
| $2.19M | ﹤0.01% |
+56,768
| New | +$2.23M |
2026 Q2
0 quarters
|
|
1978
Iovance Biotherapeutics
IOVA
$6.62B
| $2.19M | ﹤0.01% |
526,646
+52,547
| +11% | +$200K |
2015 Q4
42 quarters
|
|
1979
Shenandoah Telecom
SHEN
$519M
| $2.19M | ﹤0.01% |
145,208
+15,796
| +12% | +$249K |
2015 Q2
44 quarters
|
|
1980
Byline Bancorp
BY
$1.72B
| $2.19M | ﹤0.01% |
58,133
+3,145
| +6% | +$106K |
2021 Q2
20 quarters
|
|
1981
Ladder Capital
LADR
$1.17B
| $2.17M | ﹤0.01% |
218,589
+11,804
| +6% | +$120K |
2025 Q4
2 quarters
|
|
1982
Pennant Group
PNTG
$1.48B
| $2.17M | ﹤0.01% |
58,773
-13,627
| -19% | -$445K |
2023 Q1
13 quarters
|
|
1983
Tenaris
TS
$30.3B
| $2.17M | ﹤0.01% |
39,063
+32,191
| +468% | +$1.95M |
2025 Q4
2 quarters
|
|
1984
Barclays
BCS
$75.4B
| $2.14M | ﹤0.01% |
79,737
| – | – |
2025 Q4
2 quarters
|
|
1985
DELISTED
BioLife Solutions
BLFS
| $2.14M | ﹤0.01% |
75,790
+7,993
| +12% | +$187K |
2020 Q4
22 quarters
|
|
1986
Autohome
ATHM
$2.31B
| $2.14M | ﹤0.01% |
112,304
-26,500
| -19% | -$478K |
2025 Q4
2 quarters
|
|
1987
Mineralys Therapeutics
MLYS
$1.95B
| $2.14M | ﹤0.01% |
79,199
-338
| -0.4% | -$9.27K |
2025 Q1
5 quarters
|
|
1988
Stoke Therapeutics
STOK
$1.7B
| $2.13M | ﹤0.01% |
65,228
+7,043
| +12% | +$226K |
2024 Q2
8 quarters
|
|
1989
SSR Mining
SSRM
$5.87B
| $2.13M | ﹤0.01% |
75,409
+68,372
| +972% | +$2.08M |
2025 Q4
2 quarters
|
|
1990
Target Hospitality
TH
$1.36B
| $2.13M | ﹤0.01% |
104,692
+2,634
| +3% | +$44K |
2022 Q3
15 quarters
|
|
1991
Ryerson Holding Corp
RYZ
$1.51B
| $2.13M | ﹤0.01% |
86,588
+5
| +0% | +$132 |
2022 Q3
15 quarters
|
|
1992
Zymeworks
ZYME
$2.1B
| $2.13M | ﹤0.01% |
81,359
-238,026
| -75% | -$6.05M |
2023 Q1
13 quarters
|
|
1993
Atlas Energy Solutions
AESI
$1.1B
| $2.12M | ﹤0.01% |
127,599
-8,381
| -6% | -$137K |
2024 Q2
8 quarters
|
|
1994
GSK
GSK
$98.6B
| $2.12M | ﹤0.01% |
40,423
| – | – |
2025 Q4
2 quarters
|
|
1995
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.5B
| $2.1M | ﹤0.01% |
84,968
-644
| -0.8% | -$15.9K |
2025 Q4
2 quarters
|
|
1996
Gentherm
THRM
$1.76B
| $2.08M | ﹤0.01% |
61,056
+2,730
| +5% | +$87.9K |
2014 Q1
49 quarters
|
|
1997
Lightwave Logic
LWLG
$712M
| $2.07M | ﹤0.01% |
+218,665
| New | +$2.56M |
2026 Q2
0 quarters
|
|
1998
Dimensional Emerging Core Equity Market ETF
DFAE
$9.5B
| $2.07M | ﹤0.01% |
51,428
-1,093
| -2% | -$42.3K |
2025 Q4
2 quarters
|
|
1999
Alphatec Holdings
ATEC
$1.76B
| $2.07M | ﹤0.01% |
239,064
-33,333
| -12% | -$304K |
2020 Q4
22 quarters
|
|
2000
Apogee Enterprises
APOG
$935M
| $2.07M | ﹤0.01% |
45,165
+5,079
| +13% | +$190K |
2023 Q1
13 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.